Antares Pharma, Inc.
ATRSDelisted May 24, 2022- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001016169
Antares Pharma, Inc. was delisted on May 24, 2022; its insiders filed their last Form 4 on May 26, 2022; 177 institutions reported holding it in 13F filings for Q1 2022, worth $374.8M in total; no superinvestor held it.
Q3 2021 vs. Q2 2021
How the institutions holding Antares Pharma, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Of which not filed for Q3 2021 | Q3 2021 | Change |
|---|---|---|---|---|
| Holders | 175 | 5 | 171 | +1 |
| Shares | 82.1M | 218.2K | 82.4M | +487.3K (+0.6%) |
| Value | $358.2M | $952.0K | $300.0M | −$57.2M (−16.0%) |
5 institutions that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (20)
Institutions that held Antares Pharma, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Russell Investments Group, Ltd. | 349,593 | $1.27M | 0.00% |
| Renaissance Technologies LLC | 303,128 | $1.10M | 0.00% |
| Stonepine Capital Management, LLC | 264,100 | $961.0K | 0.44% |
| First Trust Advisors LP | 241,648 | $880.0K | 0.00% |
| Boston Partners | 117,374 | $427.0K | 0.00% |
| American Century Companies Inc | 112,203 | $408.0K | 0.00% |
| Alps Advisors Inc | 100,134 | $364.0K | 0.00% |
| Bailard, Inc. | 51,900 | $189.0K | 0.01% |
| Rafferty Asset Management, LLC | 41,867 | $152.0K | 0.00% |
| Occudo Quantitative Strategies LP | 34,912 | $127.0K | 0.02% |
| AlphaCore Capital LLC | 23,621 | $86.0K | 0.04% |
| HSBC Holdings PLC | 14,146 | $52.0K | 0.00% |
| Baker Tilly Wealth Management, LLC | 13,809 | $50.0K | 0.01% |
| Winton Group Ltd | 12,517 | $46.0K | 0.00% |
| Traynor Capital Management, Inc. | 12,000 | $43.0K | 0.01% |
| Pictet Asset Management SA | 11,300 | $41.0K | 0.00% |
| Lazard Asset Management LLC | 7,156 | $26.0K | 0.00% |
| Anfield Capital Management, LLC | 170 | $1.00K | 0.00% |
| Quadrant Capital Group LLC | 72 | $0 | 0.00% |
| Meridian Wealth Partners, LLC | 31 | $0 | 0.00% |
Sold out (19)
Institutions that held Antares Pharma, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Arrowstreet Capital, Limited Partnership | 705,033 | $3.07M |
| Brown Advisory Securities, LLC | 275,000 | $1.20M |
| HRT Financial LP | 79,484 | $346.0K |
| Spouting Rock Asset Management, LLC | 51,213 | $223.0K |
| Group One Trading, L.P. | 47,520 | $207.0K |
| Hancock Whitney Corp | 42,743 | $186.0K |
| Balyasny Asset Management LLC | 33,179 | $145.0K |
| Vontobel Holding Ltd. | 26,086 | $114.0K |
| Carderock Capital Management Inc | 25,000 | $109.0K |
| Ergoteles LLC | 24,600 | $107.0K |
| Jump Financial, LLC | 22,900 | $100.0K |
| XTX Topco Ltd | 20,657 | $90.0K |
| Cubist Systematic Strategies, LLC | 18,631 | $81.0K |
| PDT Partners, LLC | 17,086 | $74.0K |
| Quantitative Systematic Strategies LLC | 11,814 | $52.0K |
| Advisory Services Network, LLC | 9,500 | $41.0K |
| Trust Co of Vermont | 1,000 | $4.00K |
| Reilly Financial Advisors, LLC | 1,000 | $4.00K |
| Paradigm, Strategies in Wealth Management, LLC | 100 | $0 |
Not filed for Q3 2021 yet (5)
Institutions that held Antares Pharma, Inc. at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| QS Investors, LLC | 120,200 | $525.0K |
| Firethorn Wealth Partners, LLC | 48,179 | $210.0K |
| CWM, LLC | 33,550 | $146.0K |
| Pictet Asset Management Ltd | 11,300 | $49.0K |
| Elmwood Wealth Management, Inc. | 5,000 | $22.0K |